🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

13 results for “Galmed Pharmaceuticals” Clear

  1. Aramchol free acid

    Galmed Pharmaceuticals

    Nonalcoholic Steatohepatitis (NASH)

    phase 3 small molecule on hold

    1 trial

  2. Aramchol

    Galmed Pharmaceuticals

    Fatty Liver

    phase 2 small molecule completed

    1 trial

  3. Aramchol

    Galmed Pharmaceuticals

    Non-Alcoholic Fatty Liver Disease

    phase 2 small molecule completed

    1 trial

  4. Aramchol

    Galmed Pharmaceuticals

    Gallstones

    phase 2 small molecule terminated

    1 trial

  5. Aramchol meglumine

    Galmed Pharmaceuticals

    Primary Sclerosing Cholangitis

    phase 2 small molecule terminated

    1 trial

  6. mFOLFOX6 + BIBF 1120

    Galmed Pharmaceuticals

    Colorectal Cancer

    phase 2 small molecule completed

    1 trial

  7. A study to compare two different aramchol formulations in healthy volunteers.

    Galmed Pharmaceuticals

    Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis

    phase 1 other active

    1 trial

  8. Aramchol

    Galmed Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  9. Aramchol

    Galmed Pharmaceuticals

    Healthy

    phase 1 small molecule active

    4 trials

  10. Aramchol

    Galmed Pharmaceuticals

    NASH

    phase 1 small molecule completed

    1 trial

  11. Aramchol free acid tablet 600mg, single dose

    Galmed Pharmaceuticals

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  12. Aramchol meglumine

    Galmed Pharmaceuticals

    Healthy

    phase 1 small molecule active

    1 trial

  13. amilo-5MER

    Galmed Pharmaceuticals

    Inflammatory Disease

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources